Stay updated on Venetoclax and Azacitidine in AML Post-Transplant Clinical Trial
Sign up to get notified when there's something new on the Venetoclax and Azacitidine in AML Post-Transplant Clinical Trial page.

Latest updates to the Venetoclax and Azacitidine in AML Post-Transplant Clinical Trial page
- Check3 days agoChange DetectedA new revision entry 'Revision: v3.6.2' was added to the Record History, replacing the previous 'Revision: v3.6.0'. This indicates a software update to the study record history page.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedOn 2026-06-08, the study status was updated to 'No longer looking for participants', indicating recruitment for this trial has closed. This change affects how users interpret the study's current availability and eligibility.SummaryDifference1%

- Check24 days agoChange DetectedA new revision tag 'Revision: v3.5.5' was added to the study record history, and the previous 'Revision: v3.5.4' entry was removed, updating the record history to reflect the latest version.SummaryDifference0.1%

- Check45 days agoChange DetectedAdds a new revision marker 'Revision: v3.5.4' in the page footer, replacing the previous 'Revision: v3.5.3'. This represents a minor metadata update reflecting a new page version rather than changes to study content.SummaryDifference0.1%

- Check67 days agoChange DetectedThe record history page’s displayed software/application revision was updated from v3.5.2 to v3.5.3, reflecting a site version change without altering the underlying study history content.SummaryDifference0.1%

- Check74 days agoChange DetectedThe record history now shows Revision: v3.5.2 as the latest entry, replacing the previous Revision: v3.5.0.SummaryDifference0.1%

Stay in the know with updates to Venetoclax and Azacitidine in AML Post-Transplant Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Venetoclax and Azacitidine in AML Post-Transplant Clinical Trial page.